Medical Design Technology

News

Subscribe to MDT Magazine News

Safety Investigation of Suspected Counterfeit Combat Application Tourniquets (C-A-T & #xae;): Initial Communication

August 9, 2010 7:37 am | by U.S. Food & Drug Administration | Comments

FDA has become aware of suspected counterfeit C-A-T ® tourniquets. The suspected counterfeit tourniquets have subtle differences in stitching, printing of the logo and molding of plastic parts. They may be packaged and labeled for a distributor other than

UK pharma launches HQ in Fall River

August 9, 2010 7:36 am | by Mass High Tech: The Journal of New England Technology | Comments

RTS Life Science, a U.K.-based pharmaceutical and biotechnology services company, has established its U.S. headquarters in Fall River, after acquiring a local firm there.

Inferior Vena Cava (IVC) Filters: Initial Communication: Risk of Adverse Events with Long Term Use

August 9, 2010 7:30 am | by U.S. Food & Drug Administration | Comments

Known long term risks associated with IVC filters include lower limb deep vein thrombosis, filter fracture, filter migration, filter embolization and IVC perforation.

TOPICS:
Advertisement

USDA gives $3M to 4 rural Indiana phone companies

August 9, 2010 6:45 am | by The Associated Press | Comments

Four rural Indiana telephone companies will get a total of more than $3 million in federal stimulus funding to provide DSL broadband service to their service areas.The U.S. Department of Agriculture says the grants will bring the high-speed Internet service to about 2,500 homes and about 80...

MedNetworks raises $5M

August 9, 2010 6:38 am | by Mass High Tech: The Journal of New England Technology | Comments

MedNetworks Inc., a social networking-focused technology firm for doctors and patients, has launched today, taking in $5 million in its first funding round from Excel Venture Management.

Ford Blue Oval Scholarships Awarded at 3rd Annual Future Founders Academy — Winning High School Students Honored by Mayor Daley and City Council

August 9, 2010 6:37 am | by Society of Manufacturing Engineers | Comments

CHICAGO, ILL, DEARBORN, Mich., July 28, 2010 — Twenty-five students from eight Chicago Public High Schools were immersed in entrepreneurship at the 2010 Future Founders Academy as they competed in a weeklong interactive summer business camp hosted by the Chicagoland Entrepreneurial...

Revivexxx Extra Strength: Recall - Undeclared Drug Ingredient

August 9, 2010 5:42 am | by U.S. Food & Drug Administration | Comments

Product marketed as a dietary supplement sexual enhancer for men contains undeclared tadalafil, which may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels.

Solo Slim, Solo Slim Extra Strength: Recall - Undeclared Drug Ingredient

August 9, 2010 5:42 am | by U.S. Food & Drug Administration | Comments

Product contains undeclared didesmethyl sibutramine, which may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.

Advertisement

Sleep tech firm Zeo wakes up to $1M debt funding

August 9, 2010 5:40 am | by Mass High Tech: The Journal of New England Technology | Comments

Sleep technology company Zeo Inc. of Newton, originally called Axon Labs, has raised $1 million of a planned $1.5 million round of new debt funding.

TOPICS:

Public Workshop - Optimizing Clinical Trial Design for the Development of Pediatric Cardiovascular Devices, September 30th, 2010

August 9, 2010 5:30 am | by U.S. Food & Drug Administration | Comments

Rarely have devices been developed, evaluated and approved specifically for treatment of children with congenital heart disease. The small, heterogeneous population, need for long-term follow-up, lack of market incentive, and misperceptions of...

TOPICS:

Federal Register: Workshop on Optimizing Clinical Trial Design for the Development of Pediatric Cardiovascular Devices

August 9, 2010 5:30 am | by U.S. Food & Drug Administration | Comments

The topic to be discussed is pediatric cardiovascular device development. The purpose of the public workshop is to solicit information from clinicians, academia, professional societies, other government agencies, and industry on various efficient and...

TOPICS:

Ben-Gurion University of the Negev professor awarded the 2010 Elkeles Prize for Cancer Research

August 8, 2010 8:41 pm | by EurekAlert | Comments

(American Associates, Ben-Gurion University of the Negev) The pioneering studies of Apte's group demonstrated the feasibility of intervening in malignant process by neutralizing inflammatory components in the "normal" microenvironment of a tumor. They also detailed the basic...

TOPICS:

Connecting Electronic Medical Records

August 8, 2010 8:39 pm | by Massachusetts Institute of Technology | Comments

The power of search engines is applied to health-care data.

Alchimer Workshop at Semicon 2010

August 8, 2010 5:37 pm | by I-Micronews | Comments

Alchimer who recently received an investment from the Panasonic group held a workshop at Semicon West in San Francisco highlighting their "fully wet" 3D process.

Genome study identifies genetic variant linked to TB susceptibility in Africans

August 8, 2010 10:38 am | by EurekAlert | Comments

(Wellcome Trust) Scientists have identified a genetic variant which increases susceptibility to tuberculosis in African populations using a technique known as a genome-wide association study. This is the first novel disease variant to be identified using this technique in Africans...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading